NEW YORK (Reuters Health) – A pooled analysis of two trials indicates that HIV patients with aggressive B-cell non-Hodgkin lymphoma (NHL) fare better with a regimen of rituximab…
NEW YORK (Reuters Health) – In populations with low prevalence of latent tuberculosis infection, the majority of positive results on the tuberculin skin test (TST) and the newer…
NEW YORK (Reuters Health) – In pregnant HIV-infected women treated with a single intrapartum dose of nevirapine (NVP) to prevent vertical HIV transmission, the subsequent selection of nevirapine-resistant…
NEW YORK (Reuters Health) – Moxifloxacin is as effective as amoxicillin/clavulanic acid in the treatment of exacerbations of chronic obstructive pulmonary disease (COPD) in the outpatient setting, according…
NEW YORK (Reuters Health) – Cirrhosis and hepatitis are associated with the occurrence of hepatocellular carcinoma (HCC) in patients with diabetes, and hepatitis C is of particular importance,…
NEW YORK (Reuters Health) Results of a retrospective study confirm that the Rule of 7’s prediction tool accurately identifies children who are unlikely to have Lyme meningitis, investigators…
NEW YORK (Reuters Health) – The incidence of tuberculosis diagnosis is significantly higher than normal in the 6 months following pregnancy, according to the findings of a national…
NEW YORK (Reuters Health) – High-dose daptomycin appears to be a safe and effective therapeutic option for cardiac implantable electronic device (CIED)-related infective endocarditis due to staphylococci, clinicians…
NEW YORK (Reuters Health) – Patients with Kawasaki disease that is likely to be refractory, based on a standardized scoring system, respond well to primary treatment with a…
NEW YORK (Reuters Health) – Outcomes of bloodstream infections due to methicillin-resistant Staphylococcus aureus (MRSA) with elevated vancomycin minimum inhibitory concentration (MICs) are better when treated with daptomycin…